Combatting HIV Or Other STIs Early (CHOOSE)
NCT07510048
This study is recruiting at 6 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- HIV
- STIs
- STIs Prevention
- HIV Prevention
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 13 to 24 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Westat
- Last updated on ClinicalTrials.gov
- October 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- San Francisco Department of Public Health · San Francisco, CA
District of Columbia · 1
- Children's National Medical Center · Washington D.C., DC
Florida · 1
- University of South Florida · Tampa, FL
Illinois · 1
- University Illinois Chicago · Chicago, IL
Louisiana · 1
- Tulane University · New Orleans, LA
Tennessee · 1
- St. Jude Children's Research Hospital · Memphis, TN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.